Cubist Pharmaceuticals, Inc. (NASDAQ:CBST)

CAPS Rating: 4 out of 5

A biopharmaceutical company focused on the research, development and commercialization of pharmaceutical products that address unmet medical needs in the acute care environment.

Recs

0
Player Avatar kevinim89 (< 20) Submitted: 1/12/2010 5:01:37 PM : Outperform Start Price: $19.15 CBST Score: +92.27

good

Featured Broker Partners


Advertisement